MYGN Myriad Genetics RESULTS: Q2, Q2 REV $190.7M vs. EST $206M, Q2 operating expenses $165.9M, Q2 ADJ operating expenses $150.5M, Q2 Operati
MYGN Myriad Genetics RESULTS: Q2, Q2 REV $190.7M vs. EST $206M, Q2 operating expenses $165.9M, Q2 ADJ operating expenses $150.5M, Q2 Operating Income $-38.9M, Q2 gross margin 66.6%
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.